Results 191 to 200 of about 7,723,373 (378)
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
Molecular Oncology, EarlyView.The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche +8 more
wiley +1 more source
Flexible Transmission Network Planning Considering the Impacts of Distributed Generation [PDF]
The restructuring of global power industries has introduced a number of challenges, such as conflicting planning objectives and increasing uncertainties,to transmission network planners.
John Foster, Junhua Zhao
core
Molecular Oncology, EarlyView.Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef +10 more
wiley +1 more source
Solid Oxide Fuel Cell Hybrid System for Distributed Power Generation
, 2004 Nguyễn Văn Minh
+5 more sources
Maximising distributed generation capacity in deregulated markets [PDF]
, 2004 Gareth Harrison, A. R. Wallace
openalex +1 more source
Molecular Oncology, EarlyView.Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon +13 more
wiley +1 more source
Robust load frequency regulation in a new distributed generation environment [PDF]
, 2004 Hassan Bevrani +2 more
openalex +1 more source
Molecular Oncology, EarlyView.In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková +14 more
wiley +1 more source
Quantitative analysis of distributed and centralized development of renewable energy
Global Energy Interconnection, 2018 Global renewable energy has maintained a steady growth in recent years, mainly fostered by national policies and increasing demand. Analyzing the experience of renewable energy development in developed countries can be important to provide reference and ...
Xiaolu Wang +4 more
doaj